Myocardial perfusion/metabolism mismatch and ventricular arrhythmias in the chronic post infarction state

NuklearMedizin

Volumn 44, Issue 3, 2005, Pages 69-75

  Krause, Bernd J ^a,d   Poeppel, T D ^a   Reinhardt, M ^b   Vester, E G ^c   Yong, M ^a   Mau, J ^a   Strauer, B E ^a   Vosberg, H ^a   Muller H W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Praxis für Radiologie und Nuklearmedizin   (Germany)

^c Children s Hospital   (Germany)

^d Abteilung Nuklearmedizin   (Germany)

Author keywords

Post infarction state; Ventricular arrhythmias; Viable myocardium

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; NITRATE; PHENPROCOUMON; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG UPTAKE; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 20444437271     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625688     Document Type: Article

References (40)

1. Altehoefer C, Kaiser HJ, Dörr R et al. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992; 19: 334-42.
2. Altehoefer C, vom Dahl J, Biedermann M et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35: 569-74.
3. Berman DS, Kiat H, Friedman JD et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993; 22: 1455-64.
4. Breithardt G, Borggrefe M, Martinez-Rubio A et al. Pathophysiological mechanisms of ventricular tachyarrhythmias. Eur Heart J 1989; 10 Suppl E: 9-18.
5. Brunken R, Tillisch J, Schwaiger M et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951-63.
6. Büll U, Foroutan Y, Hellwig D et al. Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI [in German]. Nuklearmedizin 1995; 34: 223-8.
7. Cleland JG, Chattopadhyay S, Khand A et al. Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail Rev 2002; 7: 229-42.
8. Cobb LA, Weaver WD. Exercise: a risk for sudden death in patients with coronary heart disease. J Am Coll Cardiol 1986; 7: 215-9.
9. Cohen M, Wiener I, Pichard A et al. Determinants of Ventricular- Tachycardia in Patients with Coronary-Artery Disease and Ventricular Aneurysm - Clinical, Hemodynamic, and Angiographic Factors. American Journal of Cardiology 1983; 51: 61-4.
10. de Bakker JM, van Capelle FJ, Janse MJ et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988; 77: 589-606.
11. Di Carli MF, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-33.
12. Dillon SM, Allessie MA, Ursell PC et al. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of sub-acute canine infarcts. Circ Res 1988; 63: 182-206.
13. Doherty JU, Kienzle MG, Waxman HL et al. Relation of mode of induction and cycle length of ventricular tachycardia: analysis of 104 patients. Am J Cardiol 1983; 52: 60-4.
14. Gioia G, Bagheri B, Gottlieb CD et al. Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implan table cardioverter-defibrillators using SPECT perfusion imaging. Circulation 1997; 95: 390-4.
15. Gorlin R, Klein MD, Sullivan JM. Prospective Correlative Study of Ventricular Aneurysm-Mechanistic Concept and Clinical Recognition. American Journal of Medicine 1967; 42: 512-&.
16. Janse MJ, Vermeulen JT, Opthof T et al. Arrhythmogenesis in heart failure. J Cardiovasc Electrophysiol 2001; 12: 496-9.
17. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989; 69: 1049-169.
18. Jelinek MV, Lohrbauer L, Lown B. Antiarrhythmic drug therapy for sporadic ventricular ectopic arrhythmias. Circulation 1974; 49: 659-66.
19. Josephson ME, Horowitz LN, Farshidi A. Continuous local electrical activity. A mechanism of recurrent ventricular tachycardia. Circulation 1978; 57: 659-65.
20. Josephson ME, Horowitz LN, Farshidi A et al. Recurrent Sustained Ventricular Tachycardia .1. Mechanisms. Circulation 1978; 57: 431-40.
21. Josephson ME, Horowitz LN, Farshidi A et al. Recurrent Sustained Ventricular Tachycardia .2. Endocardial Mapping. Circulation 1978; 57: 440-7.
22. Josephson RA, Papa LA, Brooks MM et al. Effect of age on postmyocardial infarction ventricular arrhythmias (Holler Registry data from CAST I and CAST II). Cardiovascular Arrhythmia Suppression Trials. Am J Cardiol 1995; 76: 710-3.
23. Kannel WB, Plehn JF, Cupples LA. Cardiac-Failure and Sudden-Death in the Framingham-Study. American Heart Journal 1988; 115: 869-75.
24. Kempf FC, Jr., Josephson ME. Cardiac arrest recorded on ambulatory electrocardiograms. Am J Cardiol 1984; 53: 1577-82.
25. Koch KC, vom Dahl J, Wenderdel M et al. Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization. J Am Coll Cardiol 2001; 38: 91-8.
26. Margolis JR, Hirshfeld JW, Jr., McNeer JF et al. Sudden death due to coronary artery disease. A clinical, hemodynamic, and angiographic profile. Circulation 1975; 52: III180-III188.
27. Margonato A, Bonetti F, Mailhac A et al. Intravenous nitroglycerin suppresses exercise-induced arrhythmias in patients with ischaemic heart disease: implications for long-term treatment. Eur Heart J 1991; 12: 1278-82.
28. Margonato A, Mailhac A, Bonetti F et al. Exercise-induced ischemic arrhythmias in patients with previous myocardial infarction: role of perfusion and tissue viability. J Am Coll Cardiol 1996; 27: 593-8.
29. Matsunari I, Fujino S, Taki J et al. Myocardial viability assessment with technetium-99mtetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995; 36: 1961-7.
30. Molajo AO, Summers GD, Bennett DH. Effect of percutaneous transluminal coronary angioplasty on arrhythmias complicating angina. Br Heart J 1985; 54: 375-7.
31. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine 2002; 346: 877-83.
32. Packer M. Lack of Relation Between Ventricular Arrhythmias and Sudden-Death in Patients with Chronic Heart-Failure. Circulation 1992; 85: 50-6.
33. Podrid PJ, Fogel RI, Fuchs TT. Ventricular arrhythmia in congestive heart failure. Am J Cardiol 1992; 69: 82G-95G.
34. Rasmussen K, Lunde PI, Lie M. Coronary bypass surgery in exercise-induced ventricular tachycardia. Eur Heart J 1987; 8: 444-8.
35. Reiter MJ. Effects of mechano-electrical feedback: Potential arrhythmogenic influence in patients with congestive heart failure. Cardiovascular Research 1996; 32: 44-51.
36. Schelbert HR. Metabolic imaging to assess myocardial viability. J Nucl Med 1994; 35: 8S-14S.
37. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-78.
38. vom Dahl J, Altehoefer C, Sheehan FH et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med 1997; 38: 742-8.
39. vom Dahl J, Altehöfer C, Buchin P et al. Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease. Z Kardiol 1996; 85: 868-81.
40. Weiss JN, Nademanee K, Stevenson WG et al. Ventricular arrhythmias in ischemic heart disease. Ann Intern Med 1991; 114: 784-97.